A series of nontransformed human and murine cells and derivative cell lines transformed by methylcholanthrene; by simian virus 40, Kirsten and Moloney murine sarcoma viruses, simian sarcoma virus, and adenovirus; and by a "spontaneous" event in culture were examined for the expression of receptors for the platelet-derived growth factor (PDGF) and for production of substances able to compete with 1251-labeled PDGF for binding to the cell-surface PDGF receptor. In each case, transformation resulted in a 50-100% decrease in available PDGF receptors. All transformed cells except the methylcholanthrene-transformed mouse cells produce a PDGF competitor into the conditioned medium. Levels of PDGF competitor in conditioned medium at the end of a 48-hr collection were as high as 2 ng/ml-high enough to be measured by radioreceptor assay diluted 1:30 and to maximally stimulate [3H]thymidine incorporation by human fibroblasts.
Oncogenically transformed animal cells often differ from their nontransformed counterparts in two properties that are relatively easy to demonstrate in culture: they often require lower concentrations of serum for optimal growth (1-6) and they often grow when suspended in soft agar (7) . One possible explanation for these differences, termed the "autocrine hypothesis" by Sporn and Todaro (8) , is that transformed cells produce a factor(s) that stimulates their own growth in monolayer or in suspension culture (9) . Such factors, termed "transforming growth factors" (TGFs) (10) have been strongly implicated in mediating transformation by Kirsten and Moloney murine sarcoma viruses (8, 11) . TGFs secreted by these cells can compete with epidermal growth factor (EGF) for binding to cell-surface EGF receptors (11, 12) .
However, not all transformed cells secrete an EGF-like TGF (13) . Recently, production of platelet-derived growth factor (PDGF)-like molecules by an osteosarcoma cell line (14) , by a cloned glioma cell line (15) , and by simian virus 40 (SV40)-and simian sarcoma virus (SSV)-transformed 3T3 cells (16, 17) has been reported. In addition, homology between p28s"s, the oncogene product of SSV, and PDGF has been demonstrated (18, 19) . Because of the possibility that autocrine secretion of PDGF or PDGF-like molecules could be important in decreasing the mitogen requirement of monolayer cultures of transformed cells and in permitting growth in soft agar, we have investigated the expression of PDGF receptors and the production of substances competing for PDGF binding (PDGF-c) using a series of nontransformed cell lines and derivative cell lines transformed by a wide spectrum of transforming agents, as well as two cell lines from naturally occurring human tumors.
MATERIALS AND METHODS
Procedures and Materials. Binding and other procedures are described in the figure legends. Pure PDGF and 125I-labeled PDGF (125I-PDGF) were prepared as described (20) (21) (22) . Monospecific antiserum to pure PDGF (E. Raines, personal communication) was prepared in a goat. IgG was prepared by sodium sulfate precipitation and DEAE Sephacel chromotography.
Cells. Adenovirus-transformed rat embryo cells were obtained from J. Lewis (University of Washington). Mouse Swiss/3T3 and their SV40 transformants (Swiss/3T3 SV 101) were obtained from R. Pollack (Columbia University).
Swiss/3T3 D1 is a clone from the above 3T3 selected in our laboratory for quiescence in PDGF-deficient medium and for responsiveness to added PDGF. Swiss/3T3 TRD1 is a "spontaneously" transformed variant of Swiss/3T3 D1 found as a colony of rounded actively growing cells in a culture of quiescent cells and has been cloned and recloned by dilute plating. Human well at the conclusion of the assay. Binding was terminated by rinsing 4 times with binding rinse and cell-bound 1251-PDGF was determined by extracting each culture with 1 ml of 0.1% Triton X-100 with 0.1% bovine serum albumin and gamma counting the entire extract. All measurements were made using triplicate wells and are plotted as the mean. Nonspecific binding was relatively independent of cell type and averaged -0.7% of input cpm. Conditioned medium, units/ml FIG. 3. Competition by conditioned media for '25I-PDGF binding to human fibroblasts. Conditioned media were prepared by incubating confluent cultures in 150-cm2 dishes in 20 ml of culture medium containing 0.5% PDGF-deficient calf serum. This medium was discarded and replaced with fresh medium and reincubated for 48 hr. This conditioned medium was collected, debris was removed by centrifugation, and medium was concentrated 10-fold by ultrafiltration using an Amicon PM-10 membrane. The number of attached cells present at the end of the collection period was determined using an electronic particle counter. Conditioned media were assayed for PDGF-c content as described (22) . Standard Table 3 shows that antibodies against PDGF remove significant amounts of mitogenic activity from medium conditioned by transformed cells. The mitogenic activity that is not neutralized may be due to the noncrossreactive forms of PDGF-c (Fig. 4) or to unrelated mitogens. In the case Qf medium conditioned by human endothelial cells, all PDGF-c is removed by anti-PDGF (ref. 24 ; Fig.  4 ) and the remaining mitogenic activity is due to other classes of mitogens (24) . recognized by an anti-PDGF antibody that removes 20-80% of the binding activity (Fig. 4) and also removes mitogenic activity (Table 3 ). The inability of antibody to PDGF to remove all PDGF-competing activity from conditioned medium may reflect relatively small differences in the biosynthesis of PDGF by transformed cells and by megakaryocytes and endothelial cells-differences that alter antigenic crossreactivity without affecting ability to bind to the PDGF receptor. The ability of the anti-PDGF to recognize some Cell Biology: Bowen-Pope et aL 2400 Cell Biology: Bowen-Pope et al.
forms of PDGF-c allowed us to determine that these forms are mitogenic for test cells (Table 3) . We do not believe that PDGF-c is necessarily the only mitogen produced by these transformed cells. We have already shown that PDGF-like molecules account for only a fraction of the mitogens produced by vascular endothelial cells (ref. 24 ; Table 3 ). The production of mitogens in addition to PDGF-c probably accounts for the differential ability of anti-PDGF antibodies to neutralize PDGF-competing activity and to neutralize the mitogenic potency of conditioned medium. In the former case we are looking only at molecules able to bind to the PDGF receptor. In the latter case we are looking at the combined effects of all mitogens present.
Transformation Decreases the Number of PDGF Receptors.
Coincident with the production of PDGF-c by transformed cells, the number of receptors available for binding 125I-PDGF decrease to 0-50% of parental levels ( Figs. 1 and 2 ). (18, 19) . If P28"s, or a product of P28"ss, can bind to the PDGF receptor, it is possible that the PDGF-c measured in the conditioned medium of SSV-transformed NRK and NIH/3T3 cells (Fig. 3) is translated from a virally encoded message. The number of cellular genes that have been acquired by transforming viruses or that have transforming potential appears to be limited (27, 28) . The (18, 19) . This would be analogous to the synthesis of sarcoma growth factor by murine sarcoma virus-transformed cells, in which case the growth factor seems to be synthesized from a cellular gene that has been activated as a consequence of transformation (28) . Since PDGF-c from transformed cells differs from PDGF and endothelial cell PDGF-c in being incompletely or less easily neutralized by anti-PDGF antibodies (refs. 14, 15, and 23; Fig. 4 ) it is possible that PDGF-c from transformed cells is encoded by the same cellular gene that codes for platelet PDGF, but that it is processed somewhat differently (15) . It is also possible that PDGF-c is expressed from a different PDGF-like cellular gene-possibly an oncogene (29)-expressed during normal embryological development but whose expression in adult life is inappropriate.
